News
The plan – backed with a £2 billion ($2.68 billion) funding pledge – revolves around three overarching objectives, namely ...
WHO includes ArkBio' paediatric RSV drug, ziresovir in PADO-RSV priority list: Shanghai, China Thursday, July 17, 2025, 14:00 Hrs [IST] Shanghai Ark Biopharmaceutical Co., Ltd. (A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback